Cart (0 Items)
Your cart is currently empty.
View ProductsAbrilumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Abrilumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade |
|---|---|
| Source | CAS 1342290-43-0 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Abrilumab,AMG 181,MEDI-7183,ITGA4_ITGB7,anti-ITGA4_ITGB7 |
| Reference | PX-TA1350 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa |
| Clonality | Monoclonal Antibody |
Description of Abrilumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade
General information on Anti-ITGA4_ITGB7[Homo sapiens] (Abrilumab) Monoclonal Antibody
Abrilumab targets both Human ITGA4 and ITGB7.Abrilumab has been investigated for the treatment of Crohn’s Disease and Ulcerative Colitis.
Related products
Antigen
ITGA4 recombinant protein
PX-P5178 385€
SIL
Reviews
Il n’y a pas encore d’avis.